Ethyl 3-benzylimidazo[1,5-a]pyridine-1-carboxylate

Catalog No. :
ACWXKV604
CAS No. :
885276-87-9
Molecular Formula :
C17H16N2O2
Molecular Weight :
280.33

IUPAC Name:ethyl 3-benzylimidazo[1,5-a]pyridine-1-carboxylate

Ethyl 3-benzylimidazo[1,5-a]pyridine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$76.00Login to see priceIn stockInquiry
250mg95%$129.00Login to see priceIn stockInquiry
1g95%$348.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-benzylimidazo[1,5-a]pyridine-1-carboxylate
IUPAC Nameethyl 3-benzylimidazo[1,5-a]pyridine-1-carboxylate
MDL No.MFCD06739213
Molecular FormulaC17H16N2O2
Molecular Weight280.33
SMILESO=C(C1=C2C=CC=CN2C(CC3=CC=CC=C3)=N1)OCC
InChI KeyVKBRXEXZCZPHTL-UHFFFAOYSA-N
Synonym3-BENZYL-IMIDAZO[1,5-A]PYRIDINE-1-CARBOXYLIC ACID ETHYL ESTER;Ethyl 3-benzyliMidazo[1,5-a]pyridine-1-carboxylate;Imidazo[1,5-a]pyridine-1-carboxylicacid, 3-(phenylmethyl)-, ethyl ester
CAS No.885276-87-9
PubChem CID14942531

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P304+P340-P305+P351+P338-P405

Synthetic Route by SureRoute

1. ACWXKV604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDQVW783 route compound structure diagram
    ACDQVW783138891-58-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWXKV604 route product structure diagram
    ACWXKV604885276-87-9 In Stock
Inquiry

2. ACWXKV604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDQVW783 route compound structure diagram
    ACDQVW783138891-58-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWXKV604 route product structure diagram
    ACWXKV604885276-87-9 In Stock
Inquiry

Comments (0)